Amgen Inc. (AMGN) 13D/13G Filings for Neumora Therapeutics, Inc. Common Stock (NMRA)

Amgen Inc. 13D and 13G filings for Neumora Therapeutics, Inc. Common Stock:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2023-09-27
07:30 am
Purchase
2023-09-19 13D Neumora Therapeutics, Inc. Common Stock
NMRA
AMGEN INC
AMGN
35,368,653
23.200%
35,368,653increase
(New Position)
Filing